Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
ex decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i ex » i e (Expand Search), i x (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
ex decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i ex » i e (Expand Search), i x (Expand Search)
-
641
-
642
-
643
-
644
-
645
Expansion of murine bone marrow cells <i>ex vivo</i> with Tat-MYC and Tat-Bcl-2. FACS analysis shows a continuous enrichment of the c-Kit<sup>+</sup>/Sca-1<sup>+</sup> population (lin<sup>−</sup>) whereas all other cell types decrease over a 25 day period.
Published 2014“…<p>Expansion of murine bone marrow cells <i>ex vivo</i> with Tat-MYC and Tat-Bcl-2. FACS analysis shows a continuous enrichment of the c-Kit<sup>+</sup>/Sca-1<sup>+</sup> population (lin<sup>−</sup>) whereas all other cell types decrease over a 25 day period.…”
-
646
-
647
-
648
-
649
-
650
-
651
-
652
-
653
-
654
-
655
-
656
-
657
-
658
Differential Inhibition of <i>Ex-Vivo</i> Tumor Kinase Activity by Vemurafenib in <i>BRAF</i>(V600E) and <i>BRAF</i> Wild-Type Metastatic Malignant Melanoma
Published 2013“…While basal phosphorylation profiles were similar in <i>BRAF</i> wild-type and <i>BRAF</i>(V600E) tumors, analysis with <i>ex-vivo</i> vemurafenib treatment identified a subset of 40 kinase substrates showing stronger inhibition in <i>BRAF</i>(V600E) tumor lysates, distinguishing the <i>BRAF</i> wild-type and <i>BRAF</i>(V600E) tumors. …”
-
659
-
660